Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-05

FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Original Application (Neolpharma, Inc.)

View source ↗

Summary

FDA approved an original application for a generic product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, CII (Mixed amphetamine salts (dextroamphetamine and amphetamine) tablets)

Snippet

ORIG AP for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE)